Sommario

• • ·Introduction

    Pagina :1-4

    Günter Breithardt, Jerónimo Farré, David Hayes

    Mappa Mappa  
• • ·Navigation in the mega-trials waters: reflections on the multicenter automatic defibrillator implantation trial and the antiarrhythmics versus implantable defibrillators study

    Pagina :5-7

    Jerónimo Farré

    Riassunto Riassunto Mappa Mappa
• • ·Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results

    Pagina :8-16

    Hans-Joachim Trappe, Michael Achtelik, Petra Pfitzner, Bernward Voigt, Peter Weismüller

    Riassunto Riassunto Mappa Mappa  
• • ·What is the ideal rate-adaptive sensor for patients with implantable cardioverter defibrillators: lessons from cardiac pacing

    Pagina :17-23

    Eckhard Alt

    Riassunto Riassunto Mappa Mappa  
• • ·Energy levels for defibrillation: what is of real clinical importance?

    Pagina :24-33

    Parwis C Fotuhi, Andrew E Epstein, Raymond E Ideker

    Riassunto Riassunto Mappa Mappa  
• • ·Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial

    Pagina :34-39

    Joerg Neuzner, Andreas Liebrich, Jens Jung, Ewald Himmrich, Heinz F Pitschner, Joachim Winter, Ernst G Vester, Ulrich Michel, Seah Nisam, Armin Heisel

    Riassunto Riassunto Mappa Mappa  
• • ·Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators?

    Pagina :40-44

    Josep Brugada

    Riassunto Riassunto Mappa Mappa  
• • ·Algorithm for the prevention of ventricular tachycardia onset: the prevent study

    Pagina :45-47

    Martin Fromer, Dietmer Wietholt, on behalf of the Prevent Investigators∗See . Appendix ∗

    Riassunto Riassunto Mappa Mappa  
• • ·A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach

    Pagina :48-54

    Milton M Morris, Bruce H KenKnight, Jay A Warren, Douglas J Lang

    Riassunto Riassunto Mappa Mappa  
• • ·Amiodarone and “primary” prevention of sudden death: critical review of a decade of clinical trials

    Pagina :55-63

    Jerónimo Farré, José Romero, José M Rubio, Rocı́o Ayala, Jorge Castro-Dorticós

    Riassunto Riassunto Mappa Mappa
• • ·Beta blockers: evidence versus wishful thinking

    Pagina :64-67

    Dietrich Andresen, Hans-Christoph Ehlers, Michael Wiedemann, Thomas Brüggemann

    Riassunto Riassunto Mappa Mappa
• • ·Secondary prevention of sudden death: the Dutch study, the antiarrhythmics versus implantable defibrillator trial, the cardiac arrest study Hamburg, and the Canadian implantable defibrillator study

    Pagina :68-73

    Riccardo Cappato

    Riassunto Riassunto Mappa Mappa  
• • ·The implantable cardioverter defibrillator and primary prevention of sudden death: the multicenter automatic defibrillator implantation trial and the coronary artery bypass graft (CABG)-patch trial

    Pagina :74-78

    Michael Block, Günter Breithardt

    Riassunto Riassunto Mappa Mappa  
• • ·Impact of the multicenter automatic defibrillator implantation trial on implantable cardioverter defibrillator indication trends

    Pagina :79-82

    Steven L Higgins

    Riassunto Riassunto Mappa Mappa  
• • ·Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the “poor heart”

    Pagina :83-87

    Dirk Böcker, Günter Breithardt

    Riassunto Riassunto Mappa Mappa  
• • ·The problem of out-of-hospital cardiac-arrest prevalence of sudden death in Europe today

    Pagina :88-90

    Mikael Holmberg, Stig Holmberg, Johan Herlitz

    Riassunto Riassunto Mappa Mappa  
• • ·New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II

    Pagina :91-97

    Helmut Klein, Angelo Auricchio, Sven Reek, Christoph Geller

    Riassunto Riassunto Mappa Mappa  
• • ·Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts

    Pagina :98-100

    Pedro Brugada, Ramon Brugada, Josep Brugada, Peter Geelen

    Riassunto Riassunto Mappa Mappa  
• • ·What risk should justify implantable cardioverter defibrillator therapy?

    Pagina :101-103

    J Schläpfer, L Kappenberger, M Fromer

    Riassunto Riassunto Mappa Mappa
• • ·Which strategy is “best” after myocardial infarction? the beta-blocker strategy plus implantable cardioverter defibrillator trial: rationale and study design

    Pagina :104-111

    Antonio Raviele, Maria Grazia Bongiorni, Michele Brignole, Riccardo Cappato, Alessandro Capucci, Fiorenzo Gaita, Salvatore Mangiameli, Alessandro Montenero, Roberto Pedretti, Jorge Salerno, Sergio Sermasi

    Riassunto Riassunto Mappa Mappa  
• • ·Has the survival of the heart failure population changed? lessons from trials

    Pagina :112-119

    JohnG.F Cleland, Andrew Clark

    Riassunto Riassunto Mappa Mappa  
• • ·Biventricular pacing in patients with congestive heart failure: two prospective randomized trials

    Pagina :120-123

    Leslie A Saxon, John P Boehmer, John Hummel, Salem Kacet, Teresa De Marco, Gerald Naccarelli, Emile Daoud, for the VIGOR CHF and VENTAK CHF Investigators

    Riassunto Riassunto Mappa Mappa  
• • ·Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure?

    Pagina :124-129

    Stefan Sack, Rüdiger Franz, Nikolaos Dagres, Olaf Oldenburg, Jörg Herrmann, Andrea Golles, Raimund Erbel

    Riassunto Riassunto Mappa Mappa  
• • ·The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study

    Pagina :130-135

    Angelo Auricchio, Christoph Stellbrink, Stefan Sack, Michael Block, Jürgen Vogt, Patricia Bakker, Peter Mortensen, Helmut Klein, for the PATH-CHF Study Group

    Riassunto Riassunto Mappa Mappa  
• • ·Transvenous biventricular pacing for heart failure: can the obstacles be overcome?

    Pagina :136-142

    Angelo Auricchio, Helmut Klein, Bruce Tockman, Stefan Sack, Christoph Stellbrink, Jörg Neuzner, Andrew Kramer, Jiang Ding, Thierry Pochet, Albert Maarse, Julio Spinelli

    Riassunto Riassunto Mappa Mappa  
• • ·Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia

    Pagina :143-150

    Christoph Stellbrink, Angelo Auricchio, Björn Diem, Ole-Alexander Breithardt, Michael Kloss, Friedrich A. Schöndube, Helmut Klein, Bruno J. Messmer, Peter Hanrath

    Riassunto Riassunto Mappa Mappa  
• • ·The implantable cardioverter defibrillator as a “bridge to transplant”: a viable clinical strategy?

    Pagina :151-157

    Herwig Schmidinger

    Riassunto Riassunto Mappa Mappa  
• • ·Combining nonpharmacologic therapies for advanced heart failure: the münster experience with the assist device–defibrillator combination

    Pagina :158-160

    Mario C Deng, Tonny D.T Tjan, Boulos Asfour, Rainer Gradaus, Dirk Böcker, Heinz Michael Loick, Hideo A Baba, Günter Breithardt, Hans H Scheld, Martin Borggrefe, Dieter Hammel

    Riassunto Riassunto Mappa Mappa
• • ·Evolving indications for permanent pacing

    Pagina :161-165

    David L Hayes

    Riassunto Riassunto Mappa Mappa
• • ·Clinical significance of multiple sensor options: rate response optimization, sensor blending, and trending

    Pagina :166-171

    Jacques Clémenty, Serge S Barold, Stéphane Garrigue, Dipen C Shah, Pierre Jaı̈s, Philippe Le Métayer, Michel Haı̈ssaguerre

    Riassunto Riassunto Mappa Mappa  
• • ·Taking advantage of sophisticated pacemaker diagnostics

    Pagina :172-179

    Bernd Nowak

    Riassunto Riassunto Mappa Mappa  
• • ·How smart should pacemakers be?

    Pagina :180-186

    Nadir Saoudi, Ursula Appl, Frederic Anselme, Michel Voglimacci, Alain Cribier

    Riassunto Riassunto Mappa Mappa  
• • ·Pacemaker leads: performance and progress

    Pagina :187-191

    Willem G de Voogt

    Riassunto Riassunto Mappa Mappa  
• • ·Future of bradyarrhythmia therapy systems: automaticity

    Pagina :192-201

    Bruce R Jones, Jungkuk Kim, Qingsheng Zhu, James P Nelson, Bruce H KenKnight, Douglas J Lang, Jay A Warren

    Riassunto Riassunto Mappa Mappa  
• • ·Mode switching for atrial tachyarrhythmias

    Pagina :202-210

    Richard Sutton, Zahra Stack, David Heaven, Ann Ingram

    Riassunto Riassunto Mappa Mappa  
• • ·Effect of pacing mode on morbidity and mortality: update of clinical pacing trials

    Pagina :211-213

    Janet M McComb, Guy M Gribbin

    Riassunto Riassunto Mappa Mappa
• • ·Managing atrial tachyarrhythmias in patients with implantable cardioverter defibrillators

    Pagina :214-217

    Anselm Schaumann

    Riassunto Riassunto Mappa Mappa
• • ·The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system?

    Pagina :218-226

    Armin Heisel, Jens Jung

    Riassunto Riassunto Mappa Mappa  
• • ·A new system for catheter ablation of atrial fibrillation

    Pagina :227-236

    Hugh Calkins, Jeffrey Hall, Kenneth Ellenbogen, Greg Walcott, Marshall Sherman, Wade Bowe, John Simpson, Tom Castellano, G.Neal Kay

    Riassunto Riassunto Mappa Mappa  
• • ·Multisite or alternate site pacing for the prevention of atrial fibrillation

    Pagina :237-240

    Anand R Ramdat Misier, Willem P Beukema, Henk A Oude Luttikhuis

    Riassunto Riassunto Mappa Mappa
• • ·Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation

    Pagina :241-245

    Paul Touboul

    Riassunto Riassunto Mappa Mappa